A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate cancer on MRI scans. Following the practice-changing UCL-led PROMIS and PRECISION trials, prostate MRI is now the standard first test for men with suspected prostate cancer in the UK (and many parts of the world), helping doctors avoid unnecessary invasive biopsies and detect clinically important disease earlier. However, the rapid growth in MRI‑based diagnostic pathways,